{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:46:03Z","timestamp":1747187163119,"version":"3.40.5"},"reference-count":18,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Topical sertaconazole is indicated in the treatment of vaginal or mucocutaneous fungal infections due to <jats:italic>Candida<\/jats:italic> and dermatophytosis. To our knowledge, there is no data available in the literature on the potential effects of sertaconazole during pregnancy. The aim of this study was to evaluate the potential risks of topical sertaconazole use during pregnancy for the foetus and pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The EFEMERIS database was used, which contained medications prescribed and dispensed to pregnant women in the Haute\u2010Garonne region whose pregnancy ended between July 2004 and December 2018. We compared pregnant women exposed to sertaconazole at least once during pregnancy to unexposed. Crude and adjusted odds ratios (OR) of major congenital anomalies and small gestational age at birth were estimated using logistic regression models. For other outcomes, hazard ratios (HR) were estimated by Cox regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 16,222 pregnant women (15.0%) who were given sertaconazole and 91,976 who were not. Exposure to sertaconazole during pregnancy was not associated with increased risks of any of the investigated outcomes, including natural pregnancy termination (HR<jats:sub>a<\/jats:sub>\u00a0=\u00a00.92 [0.78\u20131.08]), preterm birth (HR<jats:sub>a<\/jats:sub>\u00a0=\u00a01.06 [0.95\u20131.17]) and small for gestational age at birth (OR<jats:sub>a<\/jats:sub>\u00a0=\u00a00.78 [0.66\u20130.92]). No association between risk of major congenital anomalies overall and maternal exposure to sertaconazole during the first trimester was observed (OR<jats:sub>a<\/jats:sub>\u00a0=\u00a01.01 [0.84\u20131.21]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This is the first study involving a large number of pregnant women to assess the potential risks of sertaconazole during pregnancy. This study does not indicate an increased risk of adverse pregnancy outcome and major congenital anomalies from exposure to topical sertaconazole.<\/jats:p><\/jats:sec>","DOI":"10.1111\/myc.13422","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T05:05:07Z","timestamp":1643000707000},"page":"481-489","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database"],"prefix":"10.1111","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-9554","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Araujo","sequence":"first","affiliation":[{"name":"REGARDS Network Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory) CERPOP, INSERM UMR 1295 SPHERE team: Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation Facult\u00e9 de M\u00e9decine de Toulouse (Toulouse Faculty of Medicine) Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-9130","authenticated-orcid":false,"given":"Caroline","family":"Hurault\u2010Delarue","sequence":"additional","affiliation":[{"name":"REGARDS Network Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory) CERPOP, INSERM UMR 1295 SPHERE team: Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation Facult\u00e9 de M\u00e9decine de Toulouse (Toulouse Faculty of Medicine) Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-5650","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[{"name":"REGARDS Network Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory) CERPOP, INSERM UMR 1295 SPHERE team: Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation Facult\u00e9 de M\u00e9decine de Toulouse (Toulouse Faculty of Medicine) Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-0108","authenticated-orcid":false,"given":"Christine","family":"Damase\u2010Michel","sequence":"additional","affiliation":[{"name":"REGARDS Network Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory) CERPOP, INSERM UMR 1295 SPHERE team: Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation Facult\u00e9 de M\u00e9decine de Toulouse (Toulouse Faculty of Medicine) Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7282","authenticated-orcid":false,"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[{"name":"REGARDS Network Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory) CERPOP, INSERM UMR 1295 SPHERE team: Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation Facult\u00e9 de M\u00e9decine de Toulouse (Toulouse Faculty of Medicine) Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_12_2_1","DOI":"10.1016\/S0255-0857(21)02188-5"},{"doi-asserted-by":"publisher","key":"e_1_2_12_3_1","DOI":"10.1016\/j.arcped.2005.02.010"},{"doi-asserted-by":"publisher","key":"e_1_2_12_4_1","DOI":"10.1056\/NEJM199512283332604"},{"doi-asserted-by":"publisher","key":"e_1_2_12_5_1","DOI":"10.1016\/j.ajog.2004.07.017"},{"doi-asserted-by":"publisher","key":"e_1_2_12_6_1","DOI":"10.1016\/j.therap.2020.07.002"},{"doi-asserted-by":"publisher","key":"e_1_2_12_7_1","DOI":"10.1371\/journal.pone.0219095"},{"unstructured":"These do not include all the information needed to use ERTACZO Cream safely and effectively. See full prescribing information for ERTACZO Cream. ERTACZO\u00ae (sertaconazole nitrate) cream for topical useInitial U.S. Approval;2003. [Internet]. [cited 2021 May 10]. Available from:https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=821073f7\u201033f6\u2010464d\u2010baed\u2010f66d97987d6d&amp;type=display","key":"e_1_2_12_8_1"},{"issue":"5","key":"e_1_2_12_9_1","first-page":"739","article-title":"Reproduction toxicity of sertaconazole. Segment II (teratology) and Segment III (peri\u2010postnatal toxicity)","volume":"42","author":"Romero A","year":"1992","journal-title":"Arzneimittelforschung"},{"doi-asserted-by":"publisher","key":"e_1_2_12_10_1","DOI":"10.1007\/s00228-009-0647-2"},{"doi-asserted-by":"publisher","key":"e_1_2_12_11_1","DOI":"10.1016\/j.jgyn.2006.09.001"},{"doi-asserted-by":"publisher","key":"e_1_2_12_12_1","DOI":"10.1210\/jc.2006-2017"},{"doi-asserted-by":"publisher","key":"e_1_2_12_13_1","DOI":"10.1093\/aje\/kwm324"},{"doi-asserted-by":"publisher","key":"e_1_2_12_14_1","DOI":"10.2515\/therapie\/2014207"},{"unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit \u2010 Monazol[Internet]. [cited 2021 May 10]. Available from:https:\/\/agence\u2010prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=66726382&typedoc=R&ref=R0228500.htm","key":"e_1_2_12_15_1"},{"unstructured":"Mycose de la peau \u2010 sympt\u00f4mes causes traitements et pr\u00e9vention[Internet]. VIDAL. [cited 2021 Apr 29]. Available from:https:\/\/www.vidal.fr\/maladies\/peau\u2010cheveux\u2010ongles\/mycose\u2010peau\/causes\u2010prevention.html","key":"e_1_2_12_16_1"},{"doi-asserted-by":"publisher","key":"e_1_2_12_17_1","DOI":"10.1016\/j.jgyn.2013.09.013"},{"doi-asserted-by":"publisher","key":"e_1_2_12_18_1","DOI":"10.1159\/000449275"},{"unstructured":"WHO Expert Committee on Physical Status.The Use and Interpretation of Anthropometry (1993: Geneva S Organization WH. Physical status : the use of and interpretation of anthropometry report of a WHO expert committee[Internet]. World Health Organization;1995. [cited 2022 Jan 4]. Available from:https:\/\/apps.who.int\/iris\/handle\/10665\/37003","key":"e_1_2_12_19_1"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/myc.13422","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/myc.13422","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/myc.13422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T19:12:35Z","timestamp":1693077155000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/myc.13422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/myc.13422"],"URL":"https:\/\/doi.org\/10.1111\/myc.13422","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"type":"print","value":"0933-7407"},{"type":"electronic","value":"1439-0507"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"2021-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}